相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AKT/GSK3?/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis
Shuyue Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Asperuloside Prevents Peri-Implantitis via Suppression of NF-κB and ERK1/2 on Rats
Xinge Wang et al.
PHARMACEUTICALS (2022)
Finely-Tuned Calcium Oscillations in Osteoclast Differentiation and Bone Resorption
Hiroyuki Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Role of K+ and Ca2+-Permeable Channels in Osteoblast Functions
Hiroaki Kito et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss
Sang-Yong Han et al.
MOLECULES (2021)
Inhibitory Effect of a Rosmarinic Acid-Enriched Fraction Prepared from Nga-Mon (Perilla frutescens) Seed Meal on Osteoclastogenesis through the RANK Signaling Pathway
Kanokkarn Phromnoi et al.
ANTIOXIDANTS (2021)
Exosomes derived from cyclic mechanical stretch-exposed bone marrow mesenchymal stem cells inhibit RANKL-induced osteoclastogenesis through the NF-κB signaling pathway
Fei Xiao et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down-regulating c-Fos activation
Md Abdullah Al Mamun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
Yunfei Zhan et al.
FRONTIERS IN PHARMACOLOGY (2020)
N-[2-(4-Acetyl-1-Piperazinyl)Phenyl]-2-(3-Methylphenoxy)Acetamide (NAPMA) Inhibits Osteoclast Differentiation and Protects against Ovariectomy-Induced Osteoporosis
Jinkyung Lee et al.
MOLECULES (2020)
Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
Lin Mei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia
Ya-Li Chen et al.
LEUKEMIA (2019)
Continuous Compressive Force Induces Differentiation of Osteoclasts with High Levels of Inorganic Dissolution
Rieko Matsuike et al.
MEDICAL SCIENCE MONITOR (2019)
Fermented Oyster Extract Prevents Ovariectomy-Induced Bone Loss and Suppresses Osteoclastogenesis
Hye Jung Ihn et al.
NUTRIENTS (2019)
Asperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca2+ signalling and oxidative stress
Xi Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation
Kai Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
Zhen Zhang et al.
CURRENT STEM CELL RESEARCH & THERAPY (2019)
Cytochalasin Z11 inhibits RANKL-induced osteoclastogenesis via suppressing NFATc1 activation
Lu Wang et al.
RSC ADVANCES (2019)
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
Yuhao Liu et al.
THERANOSTICS (2019)
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
Kai Chen et al.
THERANOSTICS (2019)
The role of CKIP-1 in osteoporosis development and treatment
X. Peng et al.
BONE & JOINT RESEARCH (2018)
Atorvastatin inhibits osteoclast differentiation by suppressing NF-kappa B and MAPK signaling during IL-1 beta-induced osteoclastogenesis
Won-Seok Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
Barbara Siegenthaler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
Xiao Chen et al.
FASEB JOURNAL (2017)
Ubiquitination in Periodontal Disease: A Review
Sachio Tsuchida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Heme oxygenase-1 (HO-1)/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-κB activation
Sun-Uk Bak et al.
BMB REPORTS (2017)
Ethanolic extract of Schizonepeta tenuifolia attenuates osteoclast formation and activation in vitro and protects against lipopolysaccharide-induced bone loss in vivo
Ju-Young Kim et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
Kyunghee Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis
Michael I. Carr et al.
CELL REPORTS (2016)
P62: An emerging oncotarget for osteolytic metastasis
Jing Zhang et al.
JOURNAL OF BONE ONCOLOGY (2016)
Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
Shangfu Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways
Tao Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC
Peng Tan et al.
SCIENTIFIC REPORTS (2015)
Chemotherapy- and Irradiation-Induced Bone Loss in Adults with Solid Tumors
Michel D. Wissing
CURRENT OSTEOPOROSIS REPORTS (2015)
Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway
Hye Jung Ihn et al.
PLOS ONE (2015)
Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient : a case report and insight for the drug interaction between hypotensive agents and teriparatide
Tetsuya Enishi et al.
JOURNAL OF MEDICAL INVESTIGATION (2015)
(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation
Wen-Fei Chiou et al.
PLOS ONE (2014)
Modulation of c-Fos and BDNF Protein Expression in Pentylenetetrazole-Kindled Mice following the Treatment with Novel Antiepileptic Compound HHL-6
Saima Mahmood Malhi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation
Qian Liu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The ATM protein: The importance of being active
Yosef Shiloh et al.
JOURNAL OF CELL BIOLOGY (2012)
MicroRNA control of bone formation and homeostasis
Jane B. Lian et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway
Sang-il Lee et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Glycosaminoglycans Modulate RANKL-Induced Osteoclastogenesis
Ling Ling et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
NF-κB modulators in osteolytic bone diseases
Jiake Xu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Loss of ATM Impairs Proliferation of Neural Stem Cells Through Oxidative Stress-Mediated p38 MAPK Signaling
Jeesun Kim et al.
STEM CELLS (2009)
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
